Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype

References

• Semenova EA, Nagel R, Berns A. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev 2015; 29:1447-62; PMID:26220992; http://dx.doi.org/10.1101/gad.263145.115
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP. Advances in pharmacotherapy of small cell lung cancer. Expert Opin Pharmacother 2014; 15:2385-96. PMID:25255939; http://dx.doi.org/10.1517/14656566.2014.957180
   PubMed Web of Science ®Google Scholar
• Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339:580-4; PMID:23372014; http://dx.doi.org/10.1126/science.1228522
   PubMed Web of Science ®Google Scholar
• Hamilton G, Burghuber O, Zeillinger R. Circulating tumor cells in small cell lung cancer: ex vivo expansion. Lung 2015; 193:451-2; PMID:25821178; http://dx.doi.org/10.1007/s00408-015-9725-7
   PubMed Web of Science ®Google Scholar
• Hamilton G, Rath B, Klameth L, Hochmair M. Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience 2015; 2:629-34; PMID:26328272.
   PubMedGoogle Scholar
• Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27:2192-206; PMID:24142872; http://dx.doi.org/10.1101/gad.225334.113
   PubMed Web of Science ®Google Scholar
• Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 2015; 6:10697-711; PMID:25986923.
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2(6):442-54; PMID:12189386.
   PubMed Web of Science ®Google Scholar
• Yao D, Dai C, Peng S. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 2011; 9:1608-20; PMID:21840933; http://dx.doi.org/10.1158/1541-7786.MCR-10-0568
   PubMed Web of Science ®Google Scholar
• Barriere G, Fici P, Gallerani G, Fabbri F, Zoli W, Rigaud M. Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. Ann Transl Med 2014; 2:109; PMID:25489583; http://dx.doi.org/10.3978/j.issn.2305-5839.2014.10.04
   PubMedGoogle Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Meth 2012; 9:671-5; PMID:22930834.
   PubMed Web of Science ®Google Scholar
• Yu N, Zhou J, Cui F, Tang X. Circulating tumor cells in lung cancer: detection methods and clinical applications. Lung 2015; 193:157-71; PMID:25690734; http://dx.doi.org/10.1007/s00408-015-9697-7
   PubMed Web of Science ®Google Scholar
• Galván JA, Astudillo A, Vallina A, Crespo G, Folgueras MV, González MV. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors. BMC Cancer 2014; 14:855; PMID:25413006; http://dx.doi.org/10.1186/1471-2407-14-855
   PubMed Web of Science ®Google Scholar
• Tokman MG, Porter RA, Williams CL. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res 1997; 57:1785-93; PMID:9135023.
   PubMed Web of Science ®Google Scholar
• Karachaliou N, Rosell R, Viteri S. The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung. Transl Lung Cancer Res 2013; 2:172-9; PMID:25806230; http://dx.doi.org/10.3978/j.issn.2218-6751.2013.01.01
   PubMedGoogle Scholar
• Zhang S, Cui W. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J Stem Cells 2014; 6:305-11; PMID:25126380; http://dx.doi.org/10.4252/wjsc.v6.i3.305
   PubMedGoogle Scholar
• Weina K, Utikal J. SOX2 and cancer: current research and its implications in the clinic. Clin Transl Med 2014; 3:19; PMID:25114775; http://dx.doi.org/10.1186/2001-1326-3-19
   PubMedGoogle Scholar
• Vazquez-Martin A, Cufí S, López-Bonet E, Corominas-Faja B, Cuyàs E, Vellon L, Iglesias JM, Leis O, Martín AG, Menendez JA. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells. Cell Cycle 2013; 12:3471-7; PMID:24107627; http://dx.doi.org/10.4161/cc.26692
   PubMed Web of Science ®Google Scholar
• Seymour T, Nowak A, Kakulas F. Targeting Aggressive Cancer Stem Cells in Glioblastoma. Front Oncol 2015; 5:159; PMID:26258069; http://dx.doi.org/10.3389/fonc.2015.00159
   PubMed Web of Science ®Google Scholar
• Park SB, Seo KW, So AY, Seo MS, Yu KR, Kang SK, Kang KS. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ 2012; 19:534-5; PMID:22015605; http://dx.doi.org/10.1038/cdd.2011.137
   PubMed Web of Science ®Google Scholar
• Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J, Chen G. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol 2013; 6:2846-54; PMID:24294370.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang C, Gao W, Chen T1, Qian T, Hu J, Tan Y. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. Cancer Lett 2015; 361:240-50; PMID:25779673; http://dx.doi.org/10.1016/j.canlet.2015.03.008
   PubMed Web of Science ®Google Scholar
• Fendrich V, Lauth M. The role of pancreatic and duodenal homeobox 1 as a therapeutic target in pancreatic cancer. Expert Opin Ther Targets 2014; 18:1277-83. http://dx.doi.org/10.1517/14728222.2014.945427
   PubMed Web of Science ®Google Scholar
• Pedica F, Beccari S, Pedron S, Montagna L, Piccoli P, Doglioni C, Chilosi M. PDX-1 (pancreatic/duodenal homeobox-1 protein 1). Pathologica 2014; 106:315-21; PMID:25845046.
   PubMedGoogle Scholar
• Ischenko I, Petrenko O, Hayman MJ. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci USA 2014; 111:3466-71; PMID:24550494; http://dx.doi.org/10.1073/pnas.1319911111
   PubMed Web of Science ®Google Scholar
• Johnson JD, Bernal-Mizrachi E, Alejandro EU, Han Z, Kalynyak TB, Li H, Beith JL, Gross J, Warnock GL, Townsend RR, et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci USA 2006; 103(51):19575-80; PMID:17158802.
   PubMed Web of Science ®Google Scholar
• Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R. Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 1997; 17:6002-13; PMID:9315659.
   PubMed Web of Science ®Google Scholar
• Teicher BA. Targets in small cell lung cancer. Biochem Pharmacol 2014; 87:211-9; PMID:24091017; http://dx.doi.org/10.1016/j.bcp.2013.09.014
   PubMed Web of Science ®Google Scholar
• Pillai RN, Ramalingam SS. Inhibition of insulin-like growth factor receptor: end of a targeted therapy? Transl Lung Cancer Res 2013; 2:14-22; PMID:25806201; http://dx.doi.org/10.3978/j.issn.2218-6751.2012.11.05
   PubMedGoogle Scholar
• Vincent EE, Elder DJ, Curwen J, Kilgour E, Hers I, Tavaré JM. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor. PLoS One 2013; 8:e66963; PMID:23826179; http://dx.doi.org/10.1371/journal.pone.0066963
   PubMed Web of Science ®Google Scholar
• Brahmkhatri VP, Prasanna C, Atreya HS. Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int 2015; 2015:538019; PMID:25866791; http://dx.doi.org/10.1155/2015/538019
   PubMed Web of Science ®Google Scholar
• Russo VC, Azar WJ, Yau SW, Sabin MA, Werther GA. IGFBP-2: The dark horse in metabolism and cancer. Cytokine Growth Factor Rev 2015; 26:329-346; PMID:25544066; http://dx.doi.org/10.1016/j.cytogfr.2014.12.001
   PubMed Web of Science ®Google Scholar
• Johnson MA, Firth SM. IGFBP-3: a cell fate pivot in cancer and disease. Growth Horm IGF Res2014; 24:164-173; PMID:24953254; http://dx.doi.org/10.1016/j.ghir.2014.04.007
   PubMed Web of Science ®Google Scholar
• Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, Georgoulias, Theodoropoulos PA. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 2015; 15:399; PMID:25962645; http://dx.doi.org/10.1186/s12885-015-1386-7
   PubMed Web of Science ®Google Scholar
• Krohn A, Ahrens T, Yalcin A, Plönes T, Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, Claus R, Hackanson B, Burger M. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes. PLoSOne 2014; 24;9:e100249; PMID:24959847; http://dx.doi.org/10.1371/journal.pone.0100249
   PubMed Web of Science ®Google Scholar
• Chao Y, Wu Q, Shepard C, Wells A. Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis 2012; 29:39-50; PMID:21964676; http://dx.doi.org/10.1007/s10585-011-9427-3
   PubMed Web of Science ®Google Scholar
• Tsuji T, Ibaragi S, Shima K, Hu MG, Katsurano M, Sasaki A, Hu GF. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res 2008; 68:10377-86; PMID:19074907; http://dx.doi.org/10.1158/0008-5472.CAN-08-1444
   PubMed Web of Science ®Google Scholar
• Weiswald LB, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia 2015; 17:1-15; PMID:25622895; http://dx.doi.org/10.1016/j.neo.2014.12.004
   PubMed Web of Science ®Google Scholar
• Hamilton G, Rath B, Holzer S, Hochmair M. Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cell. Transl Lung Cancer Res 2016; 5:71-77; http://dx.doi.org/10.3978/j.issn.2218-6751.2015.12.12
   PubMed Web of Science ®Google Scholar